Acalculous Acute Pancreatitis in a COVID-19 Patient

  • Pedro Antunes Meireles Serviço de Medicina 2, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal; Serviço de Oncologia Médica, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
  • Filipe Bessa Serviço de Medicina 2, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
  • Pedro Gaspar Serviço de Medicina 2, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal
  • Inês Parreira Serviço de Medicina 2, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
  • Virgílio Dias Silva Serviço de Medicina 2, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal; Serviço de Medicina Intensiva, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
  • Catarina Mota Serviço de Medicina 2, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
  • Lourdes Alvoeiro Serviço de Medicina 2, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal

Keywords

SARS-CoV-2, amylase, lipase, acute pancreatitis

Abstract

Coronavirus disease 2019 (COVID-19) is a multisystemic condition caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with manifestations ranging from mild upper respiratory symptoms to cytokine storm causing acute respiratory distress syndrome. Pancreatic exocrine tissue and endocrine islets both express angiotensin-converting enzyme 2 (ACE2), the proven receptor for SARS-CoV-2 cell internalization. An increase in pancreatic enzymes has been increasingly recognized in patients with COVID-19, but little is known about the real prevalence of acute pancreatitis in this population. We report a case of acute acalculous pancreatitis in a COVID-19 patient.

VIEW THE ENTIRE ARTICLE

References

  • Liu F, Long X, Zou W, Fang M, Wu W, Li W, et al. ACE2 expression in pancreas may cause pancreas damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol 2020 Apr 2. pii: S1542-3565(20)30537-1. doi: 10.1016/j.cgh.2020.04.040 [Epub ahead of print]. Available from: https://www.medrxiv.org/content/10.1101/2020.02.28.20029181v1.

  • Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q. Pancreatic injury patterns in patients with COVID-19 pneumonia. Gastroenterology 2020 Apr 1. pii: S0016-5085(20)30409-1. doi: 10.1053/j.gastro.2020.03.055 [Epub ahead of print].

  • Anand ER, Major C, Pickering O, Nelson M. Acute pancreatitis in a COVID-19 patient [Letter to the Editor]. Br J Surg 2020 Apr 27. doi: 10.1002/bjs.11657 [Epub ahead of print].

  • Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2010:47:193–199.
  • Published: 2020-05-13

    Issue: Vol 7 No 6 (view)

    Section: Articles

    How to cite:
    1.
    Antunes Meireles P, Bessa F, Gaspar P, Parreira I, Dias Silva V, Mota C, Alvoeiro L. Acalculous Acute Pancreatitis in a COVID-19 Patient. EJCRIM [Internet]. 2020May13 [cited 2020Sep.18];7(6). Available from: https://ejcrim.com/index.php/EJCRIM/article/view/1710

    Most read articles by the same author(s)